ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements
Trident Lifeline Ltd conducted its 13th Annual General Meeting on September 26, 2026, to approve financial statements, director re-appointment, and managerial remuneration proposals.
Trident Lifeline Limited clarified to the stock exchange that recent share price movements are purely market-driven, confirming no pending undisclosed material information.
Trident Lifeline Limited received an award from PHARMEXCIL for its contribution to India's pharmaceutical exports. This recognition highlights the company's growth in global markets.
Trident Lifeline Limited has scheduled its 13th Annual General Meeting for September 26, 2026. The company concurrently released its Annual Report for the financial year 2025-26.
Trident Lifeline Ltd has revised its Book Closure dates and e-voting Cut-off date for the 13th Annual General Meeting. New Book Closure begins September 20, 2026.
Trident Lifeline (TLL) achieved ₹129 Cr consolidated revenue in FY26, a 48% increase. Strategy centers on a demand-led manufacturing model and aggressive global registration expansion.
Trident Lifeline Ltd reported revenue from operations of ₹33.7 Cr (+42.8% YoY) and net profit of ₹5 Cr (+61.3% YoY) for Q1 FY27.
Trident Lifeline achieved record FY26 revenue exceeding ₹100 crore with a 49% standalone revenue growth. The company maintains a hybrid manufacturing model focused on pharmaceutical formulation exports to emerging markets.
Trident Lifeline Ltd reported revenue from operations of ₹75.7 Cr (+52.6% YoY) and net profit of ₹11.4 Cr (+81.0% YoY) for H2 FY26.